Share on Instagram  
Background Image

#iconohash presents #bcsm

Scroll down for the #bcsm conversation report for October 20th, 2018 EST.

iconohash

the world's conversation archive

#bcsm for October 20th, 2018EST

01
11th

coming together

When it comes to participants, we ranked 11th among 432 conversations.

11th

participating

In terms of the number of posts, we ranked 11th out of 432 conversations that took place.

7th

amplification

This conversation ranked 7th out of 432 in terms of the amplification of ideas & content.

how we participated. Here's how participants reacted & engaged each other

Reactions
75%

Amplified

There were 170 reshares, 75% of posts, during the course of the conversation.

1%

Engaged

1% of participants in this conversation engaged each other 3 times.

23%

Content

23% of participants in this conversation shared a total of 5 unique pieces of content.

quick facts.

Here are the basic facts of the conversation for for October 20th, 2018.

0
Active
Participants
0
Posts
Total

meet the influencers the movers and shakers of #bcsm

02

the top of the list. Top influencers in the chat

IMPACT
@myESMO

@myESMO

ESMO - Eur. Oncology
The European Society for Medical Oncology (ESMO) supports oncology professionals in providing cancer patients with the most effective treatment and care.

@cancermd

@cancermd

Dr Sunil Verma
Medical Director, Tom Baker Cancer Centre; Professor and Head, Department of Oncology, University of Calgary

@abcdiagnosis

@abcdiagnosis

Jo Taylor
Founder of After Breast Cancer Diagnosis - #breastreconstruction, signposting, support, patient advocate, blogger, campaigner, activist, living with secondaryBC

about the participants. let's take a look at everyone who show'd up

03

top professions what are they doing when they're not in #bcsm

insight

  the top participating professions
out of 28 total

research
oncologist
director
editor
professor

gender an estimation of what the gender break down looks like
= 1 men or women

insight

Women

Men

about the content. the best content that was shared

04
Immunotherapy scores a first win against some breast cancers
For the first time, one of the new immunotherapy drugs has shown promise against breast cancer in a large study that combined it with chemotherapy to treat an aggressive form of the disease. But the benefit for most women was small, raising questions about whether the treatment is worth its high cost and side effects. Results were discussed Saturday at a cancer conference in Munich and published by the New England Journal of Medicine.
Alpelisib Combo Nearly Doubles PFS in PIK3CA-Mutant Breast Cancer
The addition of the PI3K inhibitor alpelisib to fulvestrant nearly doubled median progression-free survival compared with the endocrine therapy alone in patients with hormone receptor (HR)-positive/HER2-negative advanced breast cancer who have a PIK3CA mutation.

chat growth how is #bcsm growing over time?

05

want more? are you interested in the full data analysis for this chat? Full transcript? Longer view at chat growth?

Email us today at research@iconohash.com or schedule a tour of our custom reports. We'll be happy to work with you. We can provide the raw data or custom reports on a scheduled basis. Full data analysis includes in-depth profile data, chat growth analysis, chat reach, influence reach, location profiles, and content profiles. Full reports are delivered via sharable web-based reports or beautiful PDFs, if you prefer to print and distribute.